Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity - eBioMedicine

Cancers, Free Full-Text

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

PDF) Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Frontiers Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy

Multi-targeted immunotherapeutics to treat B cell malignancies - ScienceDirect

AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice - eBioMedicine

IJMS, Free Full-Text

Evolving roles of CD38 metabolism in solid tumour microenvironment

Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy - Frontiers

PDF) Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma